-
Eisner BH, Goldfarb DS, Pareek G. Pharmacologic treatment of kidney stone disease. Urol Clin North Am. 2013 Feb; 40(1):21-30.
-
Goldfarb DS. Evidence for inheritance of medullary sponge kidney. Kidney Int. 2013 Feb; 83(2):193-6.
-
Mehta TH, Goldfarb DS. Uric Acid stones and hyperuricosuria. Adv Chronic Kidney Dis. 2012 Nov; 19(6):413-8.
-
Goldfarb DS, Arowojolu O. Metabolic Evaluation of First-time and Recurrent Stone Formers. Urol Clin North Am. 2013 Feb; 40(1):13-20.
-
Kenny JE, Goldfarb DS. Capital punishment: what is the appropriate abbreviation for partial pressure of a gas? Am J Med Sci. 2012 Sep; 344(3):255-6.
-
Ghannoum M, Nolin TD, Goldfarb DS, Roberts DM, Mactier R, Mowry JB, Dargan PI, Maclaren R, Hoegberg LC, Laliberté M, Calello D, Kielstein JT, Anseeuw K, Winchester JF, Burdmann EA, Bunchman TE, Li Y, Juurlink DN, Lavergne V, Megarbane B, Gosselin S, Liu KD, Hoffman RS. Extracorporeal Treatment for Thallium Poisoning: Recommendations from the EXTRIP Workgroup. Clin J Am Soc Nephrol. 2012 Oct; 7(10):1682-90.
-
Nguyen TV, Goldfarb DS. The older adult patient and kidney function. Consult Pharm. 2012 Jun; 27(6):431-44.
-
Lavergne V, Nolin TD, Hoffman RS, Roberts D, Gosselin S, Goldfarb DS, Kielstein JT, Mactier R, Maclaren R, Mowry JB, Bunchman TE, Juurlink D, Megarbane B, Anseeuw K, Winchester JF, Dargan PI, Liu KD, Hoegberg LC, Li Y, Calello DP, Burdmann EA, Yates C, Laliberté M, Decker BS, Mello-Da-Silva CA, Lavonas E, Ghannoum M. The EXTRIP (EXtracorporeal TReatments In Poisoning) workgroup: Guideline methodology. Clin Toxicol (Phila). 2012 Jun; 50(5):403-13.
-
Goldfarb DS. A woman with recurrent calcium phosphate kidney stones. Clin J Am Soc Nephrol. 2012 Jul; 7(7):1172-8.
-
Leaf DE, Bukberg PR, Goldfarb DS. Laxative abuse, eating disorders, and kidney stones: a case report and review of the literature. Am J Kidney Dis. 2012 Aug; 60(2):295-8.
-
Leaf DE, Korets R, Taylor EN, Tang J, Asplin JR, Goldfarb DS, Gupta M, Curhan GC. Effect of Vitamin D Repletion on Urinary Calcium Excretion among Kidney Stone Formers. Clin J Am Soc Nephrol. 2012 May; 7(5):829-34.
-
Goldfarb DS, Curhan GC. A New CJASN Feature: CJASN's eJournal Club (eJC). Clin J Am Soc Nephrol. 2012 Jan; 7(1):2.
-
Nguyen TV, Goldfarb DS. Implications of a reduction in the hemoglobin target in erythropoiesis-stimulating agent-treated hemodialysis patients. Nephron Extra. 2011 Jan; 1(1):212-6.
-
Dorai T, Fishman AI, Ding C, Batinic-Haberle I, Goldfarb DS, Grasso M. Amelioration of renal ischemia-reperfusion injury with a novel protective cocktail. J Urol. 2011 Dec; 186(6):2448-54.
-
Kharlamb V, Schelker J, Francois F, Jiang J, Holmes RP, Goldfarb DS. Oral Antibiotic Treatment of Helicobacter pylori Leads to Persistently Reduced Intestinal Colonization Rates with Oxalobacter formigenes. J Endourol. 2011 Nov; 25(11):1781-5.
-
Slinger R, Goldfarb D, Rajakumar D, Moldovan I, Barrowman N, Tam R, Chan F. Rapid PCR detection of group A streptococcus from flocked throat swabs: a retrospective clinical study. Ann Clin Microbiol Antimicrob. 2011; 10:33.
-
Sumorok NT, Asplin JR, Eisner BH, Stoller ML, Goldfarb DS. Effect of diet orange soda on urinary lithogenicity. Urol Res. 2012 Jun; 40(3):237-41.
-
Goldfarb DS. Potential pharmacologic treatments for cystinuria and for calcium stones associated with hyperuricosuria. Clin J Am Soc Nephrol. 2011 Aug; 6(8):2093-7.
-
Goldfarb DS, MacDonald PA, Hunt B, Gunawardhana L. Febuxostat in gout: serum urate response in uric acid overproducers and underexcretors. J Rheumatol. 2011 Jul; 38(7):1385-9.
-
Garlich FM, Goldfarb DS. Have advances in extracorporeal removal techniques changed the indications for their use in poisonings? Adv Chronic Kidney Dis. 2011 May; 18(3):172-9.
-
Goldfarb DS, Harbord NB, Winchester JF. The hemodialysis machine: where the nephrologists and toxicologists meet. Adv Chronic Kidney Dis. 2011 May; 18(3):157-9.
-
Fakheri RJ, Goldfarb DS. Ambient temperature as a contributor to kidney stone formation: implications of global warming. Kidney Int. 2011 Jun; 79(11):1178-85.
-
Dalal RP, Goldfarb DS. Melamine-related kidney stones and renal toxicity. Nat Rev Nephrol. 2011 May; 7(5):267-74.
-
Keenan RT, O'Brien WR, Lee KH, Crittenden DB, Fisher MC, Goldfarb DS, Krasnokutsky S, Oh C, Pillinger MH. Prevalence of contraindications and prescription of pharmacologic therapies for gout. Am J Med. 2011 Feb; 124(2):155-63.
-
Rimer JD, An Z, Zhu Z, Lee MH, Goldfarb DS, Wesson JA, Ward MD. Crystal growth inhibitors for the prevention of L-cystine kidney stones through molecular design. Science. 2010 Oct 15; 330(6002):337-41.
-
Lieske JC, Tremaine WJ, De Simone C, O'Connor HM, Li X, Bergstralh EJ, Goldfarb DS. Diet, but not oral probiotics, effectively reduces urinary oxalate excretion and calcium oxalate supersaturation. Kidney Int. 2010 Dec; 78(11):1178-85.
-
Ranganathan N, Ranganathan P, Friedman EA, Joseph A, Delano B, Goldfarb DS, Tam P, Rao AV, Anteyi E, Musso CG. Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease. Adv Ther. 2010 Sep; 27(9):634-47.
-
Goldfarb DS. The normal saline ceremony. Am J Kidney Dis. 2010 Aug; 56(2):A28-9.
-
Liu Y, Mo L, Goldfarb DS, Evan AP, Liang F, Khan SR, Lieske JC, Wu XR. Progressive renal papillary calcification and ureteral stone formation in mice deficient for Tamm-Horsfall protein. Am J Physiol Renal Physiol. 2010 Sep; 299(3):F469-78.
-
Chillarón J, Font-Llitjós M, Fort J, Zorzano A, Goldfarb DS, Nunes V, Palacín M. Pathophysiology and treatment of cystinuria. Nat Rev Nephrol. 2010 Jul; 6(7):424-34.
-
Fertel BS, Nelson LS, Goldfarb DS. Extracorporeal removal techniques for the poisoned patient: a review for the intensivist. J Intensive Care Med. 2010 May-Jun; 25(3):139-48.
-
Eisner BH, Asplin JR, Goldfarb DS, Ahmad A, Stoller ML. Citrate, malate and alkali content in commonly consumed diet sodas: implications for nephrolithiasis treatment. J Urol. 2010 Jun; 183(6):2419-23.
-
Kenny JE, Goldfarb DS. Update on the pathophysiology and management of uric acid renal stones. Curr Rheumatol Rep. 2010 Apr; 12(2):125-9.
-
Goldfarb DS. Response to "Chemistry misconceptions associated with understanding calcium and phosphate homeostasis". Adv Physiol Educ. 2010 Mar; 34(1):23.
-
Kim Z, Goldfarb DS. Continuous renal replacement therapy does not have a clear role in the treatment of poisoning. Nephron Clin Pract. 2010; 115(1):c1-6.
-
Barash I, Ponda MP, Goldfarb DS, Skolnik EY. A pilot clinical study to evaluate changes in urine osmolality and urine cAMP in response to acute and chronic water loading in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2010 Apr; 5(4):693-7.
-
Beara-Lasic L, Pillinger MH, Goldfarb DS. Advances in the management of gout: critical appraisal of febuxostat in the control of hyperuricemia. Int J Nephrol Renovasc Dis. 2010; 3:1-10.
-
Pillinger MH, Goldfarb DS, Keenan RT. Gout and its comorbidities. Bull NYU Hosp Jt Dis. 2010; 68(3):199-203.
-
Sedlis SP, Jurkovitz CT, Hartigan PM, Goldfarb DS, Lorin JD, Dada M, Maron DJ, Spertus JA, Mancini GB, Teo KK, O'Rourke RA, Boden WE, Weintraub WS. Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease. Am J Cardiol. 2009 Dec 15; 104(12):1647-53.
-
Fakheri RJ, Goldfarb DS. Association of nephrolithiasis prevalence rates with ambient temperature in the United States: a re-analysis. Kidney Int. 2009 Oct; 76(7):798.
-
Goldfarb DS. In the clinic. Nephrolithiasis. Ann Intern Med. 2009 Aug 4; 151(3):ITC2.
-
Brady CB, Gaziano JM, Cxypoliski RA, Guarino PD, Kaufman JS, Warren SR, Hartigan P, Goldfarb DS, Jamison RL. Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study. Am J Kidney Dis. 2009 Sep; 54(3):440-9.
-
Mason DA, Goldfarb DS. The nuclear transport machinery as a regulator of Drosophila development. Semin Cell Dev Biol. 2009 Jul; 20(5):582-9.
-
Goldfarb DS, Gorovsky MA. Nuclear dimorphism: two peas in a pod. Curr Biol. 2009 Jun 9; 19(11):R449-52.
-
Yoo L, Matalon D, Hoffman RS, Goldfarb DS. Treatment of pregabalin toxicity by hemodialysis in a patient with kidney failure. Am J Kidney Dis. 2009 Dec; 54(6):1127-30.
-
Makio T, Stanton LH, Lin CC, Goldfarb DS, Weis K, Wozniak RW. The nucleoporins Nup170p and Nup157p are essential for nuclear pore complex assembly. J Cell Biol. 2009 May 4; 185(3):459-73.
-
Mason DA, Stage DE, Goldfarb DS. Evolution of the metazoan-specific importin alpha gene family. J Mol Evol. 2009 Apr; 68(4):351-65.
-
Jamison RL, Shih MC, Humphries DE, Guarino PD, Kaufman JS, Goldfarb DS, Warren SR, Gaziano JM, Lavori P. Effect of the MTHFR C677T and A1298C polymorphisms on survival in patients with advanced CKD and ESRD: a prospective study. Am J Kidney Dis. 2009 May; 53(5):779-89.
-
Bansal AD, Hui J, Goldfarb DS. Asymptomatic nephrolithiasis detected by ultrasound. Clin J Am Soc Nephrol. 2009 Mar; 4(3):680-4.
-
Goldfarb DS. How to grow a bud: an importin acts in asymmetric division. Nat Cell Biol. 2009 Mar; 11(3):243-5.
-
Goldfarb DS, Choi MJ. Future directions in nephrolithiasis research. Adv Chronic Kidney Dis. 2009 Jan; 16(1):3-4.
-
Millen JI, Krick R, Prick T, Thumm M, Goldfarb DS. Measuring piecemeal microautophagy of the nucleus in Saccharomyces cerevisiae. Autophagy. 2009 Jan; 5(1):75-81.
-
Goldfarb DS. Prospects for dietary therapy of recurrent nephrolithiasis. Adv Chronic Kidney Dis. 2009 Jan; 16(1):21-9.
-
Goodman JW, Asplin JR, Goldfarb DS. Effect of two sports drinks on urinary lithogenicity. Urol Res. 2009 Feb; 37(1):41-6.
-
Wozniak RW, Goldfarb DS. Cyclin-like oscillations in levels of the nucleoporin Nup96 control G1/S progression. Dev Cell. 2008 Nov; 15(5):643-4.
-
Pizzi LT, Bunz TJ, Coyne DW, Goldfarb DS, Singh AK. Ferric gluconate treatment provides cost savings in patients with high ferritin and low transferrin saturation. Kidney Int. 2008 Dec; 74(12):1588-95.
-
Holubek WJ, Hoffman RS, Goldfarb DS, Nelson LS. Use of hemodialysis and hemoperfusion in poisoned patients. Kidney Int. 2008 Nov; 74(10):1327-34.
-
Leaf DE, Goldfarb DS. Interpretation and review of health-related quality of life data in CKD patients receiving treatment for anemia. Kidney Int. 2009 Jan; 75(1):15-24.
-
Fertel BS, Nelson LS, Goldfarb DS. The underutilization of hemodialysis in patients with salicylate poisoning. Kidney Int. 2009 Jun; 75(12):1349-53.
-
Krick R, Muehe Y, Prick T, Bremer S, Schlotterhose P, Eskelinen EL, Millen J, Goldfarb DS, Thumm M. Piecemeal microautophagy of the nucleus requires the core macroautophagy genes. Mol Biol Cell. 2008 Oct; 19(10):4492-505.
-
Millen JI, Pierson J, Kvam E, Olsen LJ, Goldfarb DS. The luminal N-terminus of yeast Nvj1 is an inner nuclear membrane anchor. Traffic. 2008 Sep; 9(10):1653-64.
-
Qin H, Lu M, Goldfarb DS. Genomic instability is associated with natural life span variation in Saccharomyces cerevisiae. PLoS One. 2008; 3(7):e2670.
-
Mattoo A, Goldfarb DS. Cystinuria. Semin Nephrol. 2008 Mar; 28(2):181-91.
-
Ratan R, Mason DA, Sinnot B, Goldfarb DS, Fleming RJ. Drosophila importin alpha1 performs paralog-specific functions essential for gametogenesis. Genetics. 2008 Feb; 178(2):839-50.
-
Obligado SH, Goldfarb DS. The association of nephrolithiasis with hypertension and obesity: a review. Am J Hypertens. 2008 Mar; 21(3):257-64.
-
Jamison RL, Hartigan P, Kaufman JS, Goldfarb DS, Warren SR, Guarino PD, Gaziano JM. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. JAMA. 2007 Sep 12; 298(10):1163-70.
-
O'Hara JF, Bramstedt K, Flechner S, Goldfarb D. Ethical issues surrounding high-risk kidney recipients: implications for the living donor. Prog Transplant. 2007 Sep; 17(3):180-2.
-
Maw AM, Megibow AJ, Grasso M, Goldfarb DS. Diagnosis of medullary sponge kidney by computed tomographic urography. Am J Kidney Dis. 2007 Jul; 50(1):146-50.
-
Goldfarb DS, Modersitzki F, Asplin JR. A randomized, controlled trial of lactic acid bacteria for idiopathic hyperoxaluria. Clin J Am Soc Nephrol. 2007 Jul; 2(4):745-9.
-
Flechner SM, Goldfarb D, Solez K, Modlin CS, Mastroianni B, Savas K, Babineau D, Kurian S, Salomon D, Novick AC, Cook DJ. Kidney transplantation with sirolimus and mycophenolate mofetil-based immunosuppression: 5-year results of a randomized prospective trial compared to calcineurin inhibitor drugs. Transplantation. 2007 Apr 15; 83(7):883-92.
-
Huen SC, Goldfarb DS. Adverse metabolic side effects of thiazides: implications for patients with calcium nephrolithiasis. J Urol. 2007 Apr; 177(4):1238-43.
-
Bansal AD, Goldfarb DS. Hyperkalemia: newer considerations. Virtual Mentor. 2007; 9(4):295-9.
-
Kvam E, Goldfarb DS. Nucleus-vacuole junctions and piecemeal microautophagy of the nucleus in S. cerevisiae. Autophagy. 2007 Mar-Apr; 3(2):85-92.
-
Leaf DE, Goldfarb DS. Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness. J Appl Physiol. 2007 Apr; 102(4):1313-22.
-
Bini EJ, Kinkhabwala A, Goldfarb DS. Predictive value of a positive fecal occult blood test increases as the severity of CKD worsens. Am J Kidney Dis. 2006 Oct; 48(4):580-6.
-
Goodman JW, Goldfarb DS. The role of continuous renal replacement therapy in the treatment of poisoning. Semin Dial. 2006 Sep-Oct; 19(5):402-7.
-
Kvam E, Goldfarb DS. Structure and function of nucleus-vacuole junctions: outer-nuclear-membrane targeting of Nvj1p and a role in tryptophan uptake. J Cell Sci. 2006 Sep 1; 119(Pt 17):3622-33.
-
Shalkham AS, Kirrane BM, Hoffman RS, Goldfarb DS, Nelson LS. The availability and use of charcoal hemoperfusion in the treatment of poisoned patients. Am J Kidney Dis. 2006 Aug; 48(2):239-41.
-
Kvam E, Goldfarb DS. Nucleus-vacuole junctions in yeast: anatomy of a membrane contact site. Biochem Soc Trans. 2006 Jun; 34(Pt 3):340-2.
-
Finkielstein VA, Goldfarb DS. Strategies for preventing calcium oxalate stones. CMAJ. 2006 May 9; 174(10):1407-9.
-
Goldfarb DS, Coe FL, Asplin JR. Urinary cystine excretion and capacity in patients with cystinuria. Kidney Int. 2006 Mar; 69(6):1041-7.
-
Poggio ED, Hila S, Stephany B, Fatica R, Krishnamurthi V, del Bosque C, Goldfarb D, Herts B, Dennis VW, Heeger PS, Braun W. Donor kidney volume and outcomes following live donor kidney transplantation. Am J Transplant. 2006 Mar; 6(3):616-24.
-
Wolf J, Asplin JR, Goldfarb DS. Chitosan does not reduce post-prandial urinary oxalate excretion. Urol Res. 2006 Aug; 34(4):227-30.
-
Araki M, Flechner SM, Ismail HR, Flechner LM, Zhou L, Derweesh IH, Goldfarb D, Modlin C, Novick AC, Faiman C. Posttransplant diabetes mellitus in kidney transplant recipients receiving calcineurin or mTOR inhibitor drugs. Transplantation. 2006 Feb 15; 81(3):335-41.
-
Goldfarb DS. The sorcerer's stone. Pharos Alpha Omega Alpha Honor Med Soc. 2006; 69(4):36-7.
-
Ismail HR, Flechner SM, Kaouk JH, Derweesh IH, Gill IS, Modlin C, Goldfarb D, Novick AC. Simultaneous vs. sequential laparoscopic bilateral native nephrectomy and renal transplantation. Transplantation. 2005 Oct 27; 80(8):1124-7.
-
Baxter BK, Abeliovich H, Zhang X, Stirling AG, Burlingame AL, Goldfarb DS. Atg19p ubiquitination and the cytoplasm to vacuole trafficking pathway in yeast. J Biol Chem. 2005 Nov 25; 280(47):39067-76.
-
Mason DA, Shulga N, Undavai S, Ferrando-May E, Rexach MF, Goldfarb DS. Increased nuclear envelope permeability and Pep4p-dependent degradation of nucleoporins during hydrogen peroxide-induced cell death. FEMS Yeast Res. 2005 Dec; 5(12):1237-51.
-
Lieske JC, Goldfarb DS, De Simone C, Regnier C. Use of a probiotic to decrease enteric hyperoxaluria. Kidney Int. 2005 Sep; 68(3):1244-9.
-
Kvam E, Gable K, Dunn TM, Goldfarb DS. Targeting of Tsc13p to nucleus-vacuole junctions: a role for very-long-chain fatty acids in the biogenesis of microautophagic vesicles. Mol Biol Cell. 2005 Sep; 16(9):3987-98.
-
Mehandru S, Goldfarb DS. Nephrolithiasis complicating treatment of diabetes insipidus. Urol Res. 2005 Jun; 33(3):244-6.
-
Flechner SM, Feng J, Mastroianni B, Savas K, Arnovitz J, Moneim H, Modlin CS, Goldfarb D, Cook DJ, Novick AC. The effect of 2-gram versus 1-gram concentration controlled mycophenolate mofetil on renal transplant outcomes using sirolimus-based calcineurin inhibitor drug-free immunosuppression. Transplantation. 2005 Apr 27; 79(8):926-34.
-
Dolin DJ, Asplin JR, Flagel L, Grasso M, Goldfarb DS. Effect of cystine-binding thiol drugs on urinary cystine capacity in patients with cystinuria. J Endourol. 2005 Apr; 19(3):429-32.
-
Goldfarb DS, Fischer ME, Keich Y, Goldberg J. A twin study of genetic and dietary influences on nephrolithiasis: a report from the Vietnam Era Twin (VET) Registry. Kidney Int. 2005 Mar; 67(3):1053-61.
-
Goldfarb DS. Re: acute caffeine effects on urine composition and calcium kidney stone risk in calcium stone formers. J Urol. 2005 Mar; 173(3):1048; author reply 1048-9.
-
Goldfarb DS. Hyperkalemia after the publication of RALES. N Engl J Med. 2004 Dec 2; 351(23):2448-50; author reply 2448-50.
-
Hwang MT, Goldfarb DS. Uric acid stones following hepatic transplantation. Urol Res. 2004 Dec; 32(6):423-6.
-
Goldfarb D, Scheffers L. Thematic Issue "Apoptosis-like cell death programs in yeasts". FEMS Yeast Res. 2004 Nov; 5(2):99-100.
-
Jarolim S, Millen J, Heeren G, Laun P, Goldfarb DS, Breitenbach M. A novel assay for replicative lifespan in Saccharomyces cerevisiae. FEMS Yeast Res. 2004 Nov; 5(2):169-77.
-
Kvam E, Goldfarb DS. Nvj1p is the outer-nuclear-membrane receptor for oxysterol-binding protein homolog Osh1p in Saccharomyces cerevisiae. J Cell Sci. 2004 Oct 1; 117(Pt 21):4959-68.
-
Goldfarb DS, Corbett AH, Mason DA, Harreman MT, Adam SA. Importin alpha: a multipurpose nuclear-transport receptor. Trends Cell Biol. 2004 Sep; 14(9):505-14.
-
Zhu LC, Sidhu GS, Yee HT, Cassai ND, Goldfarb DS, Wieczorek RL. AA-type amyloidosis associated with non-Hodgkin's lymphoma: a case report. Hum Pathol. 2004 Aug; 35(8):1041-4.
-
Goldfarb DS. Patients at the center: in our practice, and in our use of language. ACP J Club. 2004 May-Jun; 140(3):A14; author reply A14-5.
-
Goel M, Flechner SM, Zhou L, Mastroianni B, Savas K, Derweesh I, Patel P, Modlin C, Goldfarb D, Novick AC. The influence of various maintenance immunosuppressive drugs on lymphocele formation and treatment after kidney transplantation. J Urol. 2004 May; 171(5):1788-92.
-
Strawn LA, Shen T, Shulga N, Goldfarb DS, Wente SR. Minimal nuclear pore complexes define FG repeat domains essential for transport. Nat Cell Biol. 2004 Mar; 6(3):197-206.
-
Jamison RL, Hartigan P, Gaziano JM, Fortmann SP, Goldfarb DS, Haroldson JA, Kaufman J, Lavori P, McCully KS, Robinson K. Design and statistical issues in the homocysteinemia in kidney and end stage renal disease (HOST) study. Clin Trials. 2004; 1(5):451-60.
-
Goldfarb DS. How life imitates baseball. Pharos Alpha Omega Alpha Honor Med Soc. 2004; 67(1):34-5.
-
Goldfarb DS. Microorganisms and calcium oxalate stone disease. Nephron Physiol. 2004; 98(2):p48-54.
-
Flechner SM, Zhou L, Derweesh I, Mastroianni B, Savas K, Goldfarb D, Modlin CS, Krishnamurthi V, Novick A. The impact of sirolimus, mycophenolate mofetil, cyclosporine, azathioprine, and steroids on wound healing in 513 kidney-transplant recipients. Transplantation. 2003 Dec 27; 76(12):1729-34.
-
Mason DA, Máthé E, Fleming RJ, Goldfarb DS. The Drosophila melanogaster importin alpha3 locus encodes an essential gene required for the development of both larval and adult tissues. Genetics. 2003 Dec; 165(4):1943-58.
-
Chang MA, Goldfarb DS. Occupational risk for nephrolithiasis and bladder dysfunction in a chauffeur. Urol Res. 2004 Feb; 32(1):41-3.
-
Kaufman JS, O'Connor TZ, Zhang JH, Cronin RE, Fiore LD, Ganz MB, Goldfarb DS, Peduzzi PN. Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis. J Am Soc Nephrol. 2003 Sep; 14(9):2313-21.
-
Gibney EM, Goldfarb DS. The association of nephrolithiasis with cystic fibrosis. Am J Kidney Dis. 2003 Jul; 42(1):1-11.
-
Goldfarb DS. Increasing prevalence of kidney stones in the United States. Kidney Int. 2003 May; 63(5):1951-2.
-
Derweesh IH, Flechner SM, Modlin C, Mastroianni B, Savas K, Krishnamurthi V, Goldfarb D. Ipsilateral dual-kidney transplantation using organs declined by other centers. Transplant Proc. 2003 Mar; 35(2):856-7.
-
Roberts P, Moshitch-Moshkovitz S, Kvam E, O'Toole E, Winey M, Goldfarb DS. Piecemeal microautophagy of nucleus in Saccharomyces cerevisiae. Mol Biol Cell. 2003 Jan; 14(1):129-41.
-
Xuan BH, Thi TX, Nguyen ST, Goldfarb DS, Stokes MB, Rabenou RA. Ichthyotoxic ARF after fish gallbladder ingestion: a large case series from Vietnam. Am J Kidney Dis. 2003 Jan; 41(1):220-4.
-
Shulga N, Goldfarb DS. Binding dynamics of structural nucleoporins govern nuclear pore complex permeability and may mediate channel gating. Mol Cell Biol. 2003 Jan; 23(2):534-42.
-
Goel M, Flechner SM, Ischikawa A, Induhara R, Mastroianni B, Savas K, Modlin C, Goldfarb D, Feng J, Cook DJ, Novick AC. The effect of two different cyclosporine formulations on the long-term progression to chronic rejection in renal allograft recipients. Clin Transplant. 2002 Dec; 16(6):442-9.
-
Flechner SM, Goldfarb D, Modlin C, Feng J, Krishnamurthi V, Mastroianni B, Savas K, Cook DJ, Novick AC. Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine. Transplantation. 2002 Oct 27; 74(8):1070-6.
-
Goldfarb DS, Chung S. The absence of rhabdomyolysis-induced renal failure following the World Trade Center collapse. Am J Med. 2002 Aug 15; 113(3):260.
-
Mason DA, Fleming RJ, Goldfarb DS. Drosophila melanogaster importin alpha1 and alpha3 can replace importin alpha2 during spermatogenesis but not oogenesis. Genetics. 2002 May; 161(1):157-70.
-
Goldfarb DS. Reconsideration of the 1988 NIH Consensus Statement on Prevention and Treatment of Kidney Stones: Are the Recommendations Out of Date? Rev Urol. 2002; 4(2):53-60.
-
Kaufman JS, Reda DJ, Fye CL, Goldfarb DS, Henderson WG, Kleinman JG, Vaamonde CA. Diagnostic value of iron indices in hemodialysis patients receiving epoetin. Kidney Int. 2001 Jul; 60(1):300-8.
-
Goldfarb DS, Asplin JR. Effect of grapefruit juice on urinary lithogenicity. J Urol. 2001 Jul; 166(1):263-7.
-
Nakagawa Y, Asplin JR, Goldfarb DS, Parks JH, Coe FL. Clinical use of cystine supersaturation measurements. J Urol. 2000 Nov; 164(5):1481-5.
-
Pan X, Roberts P, Chen Y, Kvam E, Shulga N, Huang K, Lemmon S, Goldfarb DS. Nucleus-vacuole junctions in Saccharomyces cerevisiae are formed through the direct interaction of Vac8p with Nvj1p. Mol Biol Cell. 2000 Jul; 11(7):2445-57.
-
Charytan D, Goldfarb DS. Indications for hospitalization of patients with hyperkalemia. Arch Intern Med. 2000 Jun 12; 160(11):1605-11.
-
Shulga N, Mosammaparast N, Wozniak R, Goldfarb DS. Yeast nucleoporins involved in passive nuclear envelope permeability. J Cell Biol. 2000 May 29; 149(5):1027-38.
-
Cataltepe S, Schick C, Luke CJ, Pak SC, Goldfarb D, Chen P, Tanasiyevic MJ, Posner MR, Silverman GA. Development of specific monoclonal antibodies and a sensitive discriminatory immunoassay for the circulating tumor markers SCCA1 and SCCA2. Clin Chim Acta. 2000 May; 295(1-2):107-27.
-
Goldfarb DS, Sly WS, Waheed A, Charney AN. Acid-base effects on electrolyte transport in CA II-deficient mouse colon. Am J Physiol Gastrointest Liver Physiol. 2000 Mar; 278(3):G409-15.
-
Goldfarb DS, Coe FL. Prevention of recurrent nephrolithiasis. Am Fam Physician. 1999 Nov 15; 60(8):2269-76.
-
Goldfarb DS. Fomepizole for ethylene-glycol poisoning. Lancet. 1999 Nov 6; 354(9190):1646.
-
Shulga N, James P, Craig EA, Goldfarb DS. A nuclear export signal prevents Saccharomyces cerevisiae Hsp70 Ssb1p from stimulating nuclear localization signal-directed nuclear transport. J Biol Chem. 1999 Jun 4; 274(23):16501-7.
-
Lingeman J, Kahnoski R, Mardis H, Goldfarb DS, Grasso M, Lacy S, Scheinman SJ, Asplin JR, Parks JH, Coe FL. Divergence between stone composition and urine supersaturation: clinical and laboratory implications. J Urol. 1999 Apr; 161(4):1077-81.
-
Zanchin NI, Goldfarb DS. The exosome subunit Rrp43p is required for the efficient maturation of 5.8S, 18S and 25S rRNA. Nucleic Acids Res. 1999 Mar 1; 27(5):1283-8.
-
Goldfarb DS, Coe FL. Beverages, diet, and prevention of kidney stones. Am J Kidney Dis. 1999 Feb; 33(2):398-400; discussion 401-3.
-
Zanchin NI, Goldfarb DS. Nip7p interacts with Nop8p, an essential nucleolar protein required for 60S ribosome biogenesis, and the exosome subunit Rrp43p. Mol Cell Biol. 1999 Feb; 19(2):1518-25.
-
Lingeman J, Mardis H, Kahnoski R, Goldfarb DS, Lacy S, Grasso M, Scheinman SJ, Parks JH, Asplin JR, Coe FL. Medical reduction of stone risk in a network of treatment centers compared to a research clinic. J Urol. 1998 Nov; 160(5):1629-34.
-
Greenberg JR, Phan L, Gu Z, deSilva A, Apolito C, Sherman F, Hinnebusch AG, Goldfarb DS. Nip1p associates with 40 S ribosomes and the Prt1p subunit of eukaryotic initiation factor 3 and is required for efficient translation initiation. J Biol Chem. 1998 Sep 4; 273(36):23485-94.
-
Goldfarb DS, Coe FL. Foscarnet crystal deposition and renal failure. Am J Kidney Dis. 1998 Sep; 32(3):519-20.
-
Kaufman JS, Reda DJ, Fye CL, Goldfarb DS, Henderson WG, Kleinman JG, Vaamonde CA. Subcutaneous compared with intravenous epoetin in patients receiving hemodialysis. Department of Veterans Affairs Cooperative Study Group on Erythropoietin in Hemodialysis Patients. N Engl J Med. 1998 Aug 27; 339(9):578-83.
-
Pan X, Goldfarb DS. YEB3/VAC8 encodes a myristylated armadillo protein of the Saccharomyces cerevisiae vacuolar membrane that functions in vacuole fusion and inheritance. J Cell Sci. 1998 Aug; 111 ( Pt 15):2137-47.
-
Asplin J, Parks J, Lingeman J, Kahnoski R, Mardis H, Lacey S, Goldfarb D, Grasso M, Coe F. Supersaturation and stone composition in a network of dispersed treatment sites. J Urol. 1998 Jun; 159(6):1821-5.
-
Lazowski P, Goldfarb DS. Images in clinical medicine. Calcified mass in a patient on long-term hemodialysis. N Engl J Med. 1998 May 14; 338(20):1427.
-
Goldfarb DS, Parks JH, Coe FL. Renal stone disease in older adults. Clin Geriatr Med. 1998 May; 14(2):367-81.
-
Roberts PM, Goldfarb DS. In vivo nuclear transport kinetics in Saccharomyces cerevisiae. Methods Cell Biol. 1998; 53:545-57.
-
Terns MP, Goldfarb DS. Nuclear transport of RNAs in microinjected Xenopus oocytes. Methods Cell Biol. 1998; 53:559-89.
-
Malik HS, Eickbush TH, Goldfarb DS. Evolutionary specialization of the nuclear targeting apparatus. Proc Natl Acad Sci U S A. 1997 Dec 9; 94(25):13738-42.
-
Zanchin NI, Roberts P, DeSilva A, Sherman F, Goldfarb DS. Saccharomyces cerevisiae Nip7p is required for efficient 60S ribosome subunit biogenesis. Mol Cell Biol. 1997 Sep; 17(9):5001-15.
-
Goldfarb DS. Whose finger is on the switch? Science. 1997 Jun 20; 276(5320):1814-6.
-
Stokes MB, Chawla H, Brody RI, Kumar A, Gertner R, Goldfarb DS, Gallo G. Immune complex glomerulonephritis in patients coinfected with human immunodeficiency virus and hepatitis C virus. Am J Kidney Dis. 1997 Apr; 29(4):514-25.
-
Goldfarb DS. Nuclear transport: proliferating pathways. Curr Biol. 1997 Jan 1; 7(1):R13-6.
-
Shulga N, Roberts P, Gu Z, Spitz L, Tabb MM, Nomura M, Goldfarb DS. In vivo nuclear transport kinetics in Saccharomyces cerevisiae: a role for heat shock protein 70 during targeting and translocation. J Cell Biol. 1996 Oct; 135(2):329-39.
-
Goldfarb D. Viruses: the Trojan horses of the cell. Trends Cell Biol. 1996 Jan; 6(1):8.
-
Goldfarb D, Lowry LD, Keane WM. Recurrent rhabdomyoma of the parapharyngeal space. Am J Otolaryngol. 1996 Jan-Feb; 17(1):58-60.
-
Goldfarb DS. HIV-1 virology. Simply Marvelous nuclear transport. Curr Biol. 1995 Jun 1; 5(6):570-3.
-
Pokrywka NJ, Goldfarb DS. Nuclear export pathways of tRNA and 40 S ribosomes include both common and specific intermediates. J Biol Chem. 1995 Feb 24; 270(8):3619-24.
-
Pruschy M, Ju Y, Spitz L, Carafoli E, Goldfarb DS. Facilitated nuclear transport of calmodulin in tissue culture cells. J Cell Biol. 1994 Dec; 127(6 Pt 1):1527-36.
-
Rackley R, Novick A, Klein E, Bukowski R, McLain D, Goldfarb D. The impact of adjuvant nephrectomy on multimodality treatment of metastatic renal cell carcinoma. J Urol. 1994 Nov; 152(5 Pt 1):1399-403.
-
Goldfarb D, Sataloff RT. Lyme disease: a review for the otolaryngologist. Ear Nose Throat J. 1994 Nov; 73(11):824-9.
-
Goldfarb D, Keane WM, Lowry LD. Laryngeal pacing as a treatment for vocal fold paralysis. J Voice. 1994 Jun; 8(2):179-85.
-
Gill IS, Novick AC, Goldfarb D. A new triple-balloon, four-channel vascular catheter for use in renal transplantation. J Urol. 1994 May; 151(5):1416-9.
-
Gulizia J, Dempsey MP, Sharova N, Bukrinsky MI, Spitz L, Goldfarb D, Stevenson M. Reduced nuclear import of human immunodeficiency virus type 1 preintegration complexes in the presence of a prototypic nuclear targeting signal. J Virol. 1994 Mar; 68(3):2021-5.
-
Rackley R, Lorig R, Goldfarb D, Kay R. Magnetic resonance imaging of pelvic tumors in children. J Urol. 1994 Feb; 151(2):449-52.
-
Goldfarb DS. Protein translocation. GTPase cycle for nuclear transport. Curr Biol. 1994 Jan 1; 4(1):57-60.
-
Bukrinsky MI, Haggerty S, Dempsey MP, Sharova N, Adzhubel A, Spitz L, Lewis P, Goldfarb D, Emerman M, Stevenson M. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature. 1993 Oct 14; 365(6447):666-9.
-
Michaud N, Goldfarb DS. Most nuclear proteins are imported by a single pathway. Exp Cell Res. 1993 Sep; 208(1):128-36.
-
Kadowaki T, Goldfarb D, Spitz LM, Tartakoff AM, Ohno M. Regulation of RNA processing and transport by a nuclear guanine nucleotide release protein and members of the Ras superfamily. EMBO J. 1993 Jul; 12(7):2929-37.
-
Gu Z, Moerschell RP, Sherman F, Goldfarb DS. NIP1, a gene required for nuclear transport in yeast. Proc Natl Acad Sci U S A. 1992 Nov 1; 89(21):10355-9.
-
Goldfarb DS. Are the cytosolic components of the nuclear, ER, and mitochondrial import apparatus functionally related? Cell. 1992 Jul 24; 70(2):185-8.
-
Michaud N, Goldfarb D. Microinjected U snRNAs are imported to oocyte nuclei via the nuclear pore complex by three distinguishable targeting pathways. J Cell Biol. 1992 Feb; 116(4):851-61.
-
Goldfarb DS, Chan AJ, Hernandez D, Charney AN. Effect of thiazides on colonic NaCl absorption: role of carbonic anhydrase. Am J Physiol. 1991 Sep; 261(3 Pt 2):F452-8.
-
Goldfarb DS. Shuttling proteins go both ways. Curr Biol. 1991 Aug; 1(4):212-4.
-
Goldfarb D, Michaud N. Pathways for the nuclear transport of proteins and RNAs. Trends Cell Biol. 1991 Jul; 1(1):20-4.
-
Charney AN, Goldfarb DS, Egnor RW. Effects of pH and cyclic adenosine monophosphate on ileal electrolyte transport in the rat and rabbit. Gastroenterology. 1991 Feb; 100(2):410-8.
-
Michaud N, Goldfarb DS. Multiple pathways in nuclear transport: the import of U2 snRNP occurs by a novel kinetic pathway. J Cell Biol. 1991 Jan; 112(2):215-23.
-
Breeuwer M, Goldfarb DS. Facilitated nuclear transport of histone H1 and other small nucleophilic proteins. Cell. 1990 Mar 23; 60(6):999-1008.
-
White EM, Allis CD, Goldfarb DS, Srivastva A, Weir JW, Gorovsky MA. Nucleus-specific and temporally restricted localization of proteins in Tetrahymena macronuclei and micronuclei. J Cell Biol. 1989 Nov; 109(5):1983-92.
-
Akey CW, Goldfarb DS. Protein import through the nuclear pore complex is a multistep process. J Cell Biol. 1989 Sep; 109(3):971-82.
-
Friedman E, Farfel Z, Goldfarb D, Gafni J. Renal tubular acidosis after prolonged remission of nephrotic syndrome in amyloidosis associated with astrocytoma. South Med J. 1989 Jun; 82(6):765-8.
-
Goldfarb DS. Nuclear transport. Curr Opin Cell Biol. 1989 Jun; 1(3):441-6.
-
Goldfarb DS. Karyophilic peptides: applications to the study of nuclear transport. Cell Biol Int Rep. 1988 Sep; 12(9):809-32.
-
Goldfarb DS, Egnor RW, Charney AN. Effects of acid-base variables on ion transport in rat colon. J Clin Invest. 1988 Jun; 81(6):1903-10.
-
Goldfarb D, Nord EP. Asymmetric affinity of Na+-H+ antiporter for Na+ at the cytoplasmic versus external transport site. Am J Physiol. 1987 Nov; 253(5 Pt 2):F959-68.
-
Goldfarb DS, Gariépy J, Schoolnik G, Kornberg RD. Synthetic peptides as nuclear localization signals. Nature. 1986 Aug 14-20; 322(6080):641-4.
-
Lin CK, Goldfarb DS, Doi RH, Rodriguez RL. Mutations that affect the translation efficiency of Tn9-derived cat gene in Bacillus subtilis. Proc Natl Acad Sci U S A. 1985 Jan; 82(1):173-7.
-
Goldfarb DS, Rodriguez RL, Doi RH. Translational block to expression of the Escherichia coli Tn9-derived chloramphenicol-resistance gene in Bacillus subtilis. Proc Natl Acad Sci U S A. 1982 Oct; 79(19):5886-90.
-
Martinowitz U, Rabinovich J, Goldfarb D, Many A, Bank H. Interaction between warfarin sodium and amiodarone. N Engl J Med. 1981 Mar 12; 304(11):671-2.
-
Sack J, Blau H, Goldfarb D, Ben-Zaray S, Katznelson D. Hyperuricosuria in cystic fibrosis patients treated with pancreatic enzyme supplements. A study of 16 patients in Israel. Isr J Med Sci. 1980 Jun; 16(6):417-9.
-
Baker LD, Johnson JM, Goldfarb D. Expanded polytetrafluoroethylene (PTFE) subcutaneous arteriovenous conduit: an improved vascular access for chronic hemodialysis. Trans Am Soc Artif Intern Organs. 1976; 22:382-7.
